News

A ‘Glimmer Of Hope’ In The Fight Against The World’s Top Infectious Killer


27 Sep 2017
by Working Group

In a sign of increasing political will in the battle against the world’s top infectious killer, the heads of the World Health Organization and USAID voiced their support for the global fight against tuberculosis last week in a reception during the United Nations General Assembly.

Advocates had been seeing a snowballing of political support to thwart tuberculosis, first with the announcement of a U.N. high-level meeting focused solely on TB next year, followed by the recent inclusion of the fight against TB in the G-20 declaration and excitement over a WHO ministerial conference on tuberculosis to be headlined by Russian President Vladimir Putin in November.  

WHO Director Tedros Adhanom Ghebreyesus spoke movingly of his brother’s fight against tuberculosis at the reception hosted Sept. 19 by the Stop TB Partnership and WHO, both part of the U.N. He stressed that TB continues to be a major problem today and that antimicrobial resistance is making it even more deadly. 

And the need for new drugs to combat tuberculosis, whose drug-resistant strains account for a third of antimicrobial-resistant (AMR) deaths, is growing. “Drug-resistant TB is the most common and lethal airborne AMR disease worldwide today, responsible for 250,000 deaths each year,” stated the WHO’s “Antibacterial Agents in Clinical Development” report, released last week.

Continue reading at HuffintonPost.com

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...